SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genta, Inc. (GNTA)
GNTA 2.300+0.4%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (1733)9/15/2003 1:45:34 PM
From: Jim Oravetz  Read Replies (1) of 1870
 
In Play: Genta tgt raised to $19 from $13 at Ryan Beck (GNTA)

Briefing.com 10:11 am September 15, 2003

13.90 -0.35: Although results from recent Phase III study are far from flawless, firm believes the FDA will approve Genasense for the treatment ofmelanoma. This conclusion is based on three primary factors, including (1) a relatively compelling data set that could improve; (2) regulatory precedent set in oncology over the last 6-12 months; and (3) the tremendous unmet medical need in melanoma.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News